Frequently debrided and misdiagnosed: Post-surgical pyoderma gangrenosum
Main Article Content
Keywords
pyoderma gangrenosum, post-operative, surgical complications
Abstract
Post-surgical pyoderma gangrenosum is rare. On average it develops 10 days after a surgical procedure. This timeframe is similar to post-operative wound infections, including post-operative necrotizing fasciitis. Consequently, post-surgical pyoderma gangrenosum is frequently misdiagnosed as an infection, leading to detrimental surgical debridement, unnecessary antibiotic use, and delay of proper treatment. We review a case of pyoderma gangrenosum of the right inguinal crease following percutaneous coronary catheterization and review of the literature.
References
2. S.N. Tolkachjov, et al.Postoperative pyoderma gangrenosum (PG): the Mayo Clinic experience of 20 years from 1994 through 2014. J. Am. Acad. Dermatol., 73 (4) (2015), pp. 615-622
3. Tolkachjov SN et al. Postoperative Pyoderma Gangrenosum: A Clinical Review of Published Cases. Mayo Clin Proc. 2016 Sep; 91(9): 1267-79.
4. Ogata K et al. Pyoderma gangrenosum in an abdominal surgical site: a case report. Surg Case Rep. 2015 Dec; 1:122.
5. Wang C et al. Immune dysregulation in myelodysplastic syndrome: Clinical features, pathogenesis, and therapeutic strategies. Crit Rev Oncol Hematol. 2018 Feb; 122. 123-132.
6. Crowson AN, Mihm MC Jr, Magro C. Pyoderma gangrenosum: a review. J Cutan Pathol. 2003 Feb; 30(2): 97-107.
7. Le Cleach L et al. Is topical monotherapy effective for localized pyoderma gangrenosum? Arch Dermatol. 2011; 147: 101-3.
8. Thomas et al. Clinical outcomes and response of patients applying topical therapy for pyoderma gangrenosum: A prospective cohort study. J Am Acad Dermatol. 2016 Nov; 75(5): 940-949.
9. Leiphart PA et al. Suppression of pathergy in pyoderma gangrenosum with infliximab allowing for successful tendon depridement. JAAD Case Rep 2017 Dec 20; 4(1): 98-100.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation.
Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.
Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.
Lindsey Wold Fraser, Dartmouth-Hitchcock Medical Center
Chief Resident
Section of Dermatology
Stephanie A Castillo, Geisel School of Medicine at Dartmouth-Hitchcock
Medical studentShabnam Momtahen, Dartmouth-Hitchcock Medical Center
Assistant Professor of Pathology
Dartmouth-Hitchcock Medical Center
Michael Shane Chapman, Dartmouth-Hitchcock Medical Center
Section Chief, Dermatology
Associate Professor of Surgery, Geisel School of Medicine